Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 180 publications
Cathepsin B-activated vitamin E prodrugs target cancer stem cells and enhance chemotherapy response in triple-negative breast cancer with minimal cardiotoxicity.
Journal: Journal of drug targeting
Published: July 27, 2026
SERENA-6 visual patient-reported outcomes & safety: camizestrant for emerging ESR1m advanced breast cancer during first-line endocrine-based therapy.
Journal: The oncologist
Published: May 22, 2026
SERENA-6 visual patient-reported outcomes and safety: camizestrant for emerging ESR1m advanced breast cancer during first-line endocrine-based therapy.
Journal: The oncologist
Published: May 22, 2026
Switching to camizestrant at ESR1 mutation emergence before disease progression during first-line treatment of hormone receptor-positive advanced breast cancer (SERENA-6): extended analysis of a double-blind, placebo-controlled, randomised, phase 3 trial.
Journal: The Lancet. Oncology
Published: April 24, 2026
Associations of neighborhood deprivation with breast cancer tumor genomics, targeted treatment use, and survival.
Journal: Breast cancer research and treatment
Published: February 15, 2026
Circulating tumor DNA in breast cancer: updates from SABCS 2025.
Journal: Journal of hematology & oncology
Published: February 08, 2026
Datopotamab deruxtecan (Dato-DXd) in combination with durvalumab as first-line treatment for unresectable locally advanced or metastatic triple-negative breast cancer: results from arms 7 and 8 of the phase Ib/II BEGONIA study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 02, 2026
Unraveling TIME: CD8+ T cell- and CXCL11-driven endocrine resistance in breast cancer.
Journal: The Journal of clinical investigation
Published: February 02, 2026
Rationale and trial design of RIBOLARIS: A phase II trial of neoadjuvant and adjuvant ribociclib plus endocrine therapy for clinically high-risk HR+/HER2-negative breast cancer.
Journal: Therapeutic advances in medical oncology
Published: January 27, 2026
Spatial Mapping of the Precancer-to-Cancer Transition in Breast and Prostate.
Journal: Cancer discovery
Published: January 11, 2026
Last Updated: 09/26/2026